Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis

BACKGROUND: What is the optimal neoadjuvant chemotherapy (NAC) regimen for locally advanced gastric cancer (LAGC) remains debatable. The objective of this study was to compare the efficacy of docetaxel+oxaliplatin+S-1 (DOS) vs oxaliplatin+S-1 (SOX) as NAC for LAGC. METHODS: Data of 248 LAGC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Huang, Hejing, Wei, Ziran, Zhu, Zhenxin, Yang, Dejun, Fu, Hongbing, Xu, Jiapeng, Hu, Zunqi, Zhang, Yu, You, Qing, Huang, Xin, Yan, Ronglin, Wang, Weimin, Cai, Qingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398747/
https://www.ncbi.nlm.nih.gov/pubmed/32801898
http://dx.doi.org/10.2147/CMAR.S258360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398747/
https://www.ncbi.nlm.nih.gov/pubmed/32801898
http://dx.doi.org/10.2147/CMAR.S258360

Ejemplares similares